First test: can immunotherapy boost Radiation's power against uterine cancer?
NCT ID NCT03955978
Summary
This study is testing whether adding a new immunotherapy drug (TSR-042) to standard radiation treatment is safe and effective for people with endometrial (uterine) cancer who cannot have surgery. It will involve about 10 participants to first check for side effects. The goal is to see if this combination can better control the cancer by helping the body's immune system fight it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.